XENO (Xeno Transplants) Other Stockholders Equity: $-0.00 Mil (As of Mar. 2008)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Xeno Transplants Other Stockholders Equity?

Xeno Transplants XENO Other Stockholders Equity is $-0.00 Mil as of Mar. 2008.

Xeno Transplants's Other Stockholders Equity for the quarter that ended in Mar. 2008 was $-0.00 Mil.

Xeno Transplants's quarterly Other Stockholders Equity increased from Sep. 2007 ($-0.00 Mil) to Dec. 2007 ($-0.00 Mil) but then stayed the same from Dec. 2007 ($-0.00 Mil) to Mar. 2008 ($-0.00 Mil).

Xeno Transplants's annual Other Stockholders Equity declined from Jun. 2005 ($0.00 Mil) to Jun. 2006 ($-0.00 Mil) but then increased from Jun. 2006 ($-0.00 Mil) to Jun. 2007 ($0.00 Mil).

Xeno Transplants Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Xeno Transplants's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Xeno Transplants Other Stockholders Equity Chart

Xeno Transplants Annual Data
Trend Jun05 Jun06 Jun07
Other Stockholders Equity
0.00 -0.00 0.00

Xeno Transplants Quarterly Data
Jun05 Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 -0.00 -0.00 -0.00

Xeno Transplants Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of $-0.00 Mil mean?
Xeno Transplants (XENO) has a Other Stockholders Equity of $-0.00 Mil as of Mar. 2008. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Xeno Transplants and its competitors.
Is Xeno Transplants' Other Stockholders Equity too high?
Xeno Transplants' current Other Stockholders Equity is $-0.00 Mil.
How does Xeno Transplants' Other Stockholders Equity compare to PRTX and GWSN?
Xeno Transplants' Other Stockholders Equity of $-0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Biotechnology company?
A good Other Stockholders Equity depends on the Biotechnology industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Xeno Transplants and its competitors. Xeno Transplants's current Other Stockholders Equity is $-0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Xeno Transplants stock overvalued right now?
Xeno Transplants (XENO) has a current Other Stockholders Equity of $-0.00 Mil. The current Other Stockholders Equity is $-0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Xeno Transplants (XENO), the current Other Stockholders Equity is $-0.00 Mil as of Mar. 2008. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Xeno Transplants Business Description

Address 143 Gardner Road, Brookline, MA, USA, 02445
Xeno Transplants Corp is a bio-technology research and development company, which intends to develop therapeutic applications of organs and cells derived from genetically engineered pigs as a transplant alternative to limited human donor sources.